✦ LIBER ✦

Long-term cyclosporin A pharmacokinetic profiles in pediatric renal transplant recipients

✍ Scribed by A. Kelles; R. Damme-Lombaerts; T. B. Tjandra-Maga; B. Damme

Publisher: Springer
Year: 1996
Tongue: English
Weight: 545 KB
Volume: 9
Category: Article
ISSN: 0934-0874
DOI: 10.1007/bf00335553

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of cyclosporine A on long-term al

Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients

✍ A. W. Williams; B. Z. Morgenstern; Mary Murphy; D. S. Milliner 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 460 KB

Impact of long-term immunosuppression wi

Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients

✍ Thomas F. Schorn; Volker Kliem; Marina Bojanovski; Dubravka Bojanovski; Heinz Re 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 511 KB

To determine the impact of long-term immunosuppression on serum lipids in stable renal graft recipients we measured serum lipids and apolipoprotein B concentrations in 20 patients receiving therapy with cyclosporin (CsA) and low-dose prednisolone (CsA/P) and in 18 patients on therapy with azathiopri

Symptomatic cholelithiasis in pediatric

Symptomatic cholelithiasis in pediatric renal transplant recipients

✍ Maria E. Diaz-Gonzalez de Ferris; Stanley A. Mendoza; William R. Griswold; Laura 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 443 KB

Long-term mycophenolate mofetil treatmen

Long-term mycophenolate mofetil treatment in pediatric renal transplant patients

✍ John P. Roberts; Donald Potter; M. René Bouw 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 86 KB

Safety, tolerability, and pharmacokineti

Safety, tolerability, and pharmacokinetic actions of diltiazem in pediatric liver transplant recipients on cyclosporine

✍ Edreesi, Mohammed Al ;Caillé, Gilles ;Dupuis, Claire ;Théoret, Yves ;Paradis, Kh 📂 Article 📅 1995 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 513 KB

Thirty-two children who had undergone liver transplantation were paired according to their posttransplantation duration, renal function, and diagnoses when possible and randomized either to continue nifedipine (NIF group) or switch to diltiazem (DIL group), in addition to continuing their usual immu

Pharmacokinetics of mycophenolate mofeti

Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine

✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req